What Are the 5 Lethal Cardiac Rhythms?

The five cardiac rhythms considered lethal in emergency medicine are ventricular fibrillation (VF), pulseless ventricular tachycardia (VT), asystole, pulseless electrical activity (PEA), and torsades de pointes. Each of these rhythms stops effective blood circulation, and without rapid intervention, any one of them leads to death within minutes. They form the core of what paramedics, emergency physicians, and nurses train to recognize and treat during cardiac arrest, but the treatment approach differs sharply depending on which rhythm is present.

Two Categories That Shape Every Resuscitation Decision

The single most important distinction during cardiac arrest is whether the rhythm on the monitor is “shockable” or “non-shockable.” VF and pulseless VT are shockable, meaning an electrical shock from a defibrillator can potentially reset the heart’s electrical activity back to a normal pattern. Asystole and PEA are non-shockable, meaning defibrillation won’t help and can actually waste precious time. Torsades de pointes sits in an unusual middle ground that we’ll get to shortly.

Resuscitation algorithms rely heavily on this binary split. As one European Heart Journal review put it, the non-shockable rhythms tend to be “treated as a monolithic entity,” which is less about clinical confidence and more about the fact that we still don’t have great ways to distinguish their management in the heat of a resuscitation.¹ Understanding each rhythm individually, though, helps make sense of why survival rates vary so dramatically from one arrest to the next.

Ventricular Fibrillation

VF is the rhythm most people picture when they think of cardiac arrest. The heart’s lower chambers quiver chaotically instead of contracting in an organized way, producing no useful blood flow. On a heart monitor, VF looks like a jagged, irregular waveform with no recognizable pattern. At the cellular level, the heart’s electrical signals are firing at an extraordinary rate, with some research documenting over 550 excitations per minute, far too fast for the muscle to actually pump.²

Despite being immediately fatal without treatment, VF is actually the most survivable of the five lethal rhythms if caught quickly. That’s because defibrillation is highly effective at terminating it, especially in the first few minutes. The chaotic electrical storm can be “reset” by a single shock, giving the heart a chance to resume a normal rhythm. This is why automated external defibrillators (AEDs) exist in airports, gyms, and office buildings: they are built to detect VF (and pulseless VT) and deliver that lifesaving shock.

Pulseless Ventricular Tachycardia

Ventricular tachycardia is a dangerously fast heart rate originating in the ventricles. When the rate gets high enough or the heart is already weakened, VT can fail to produce a detectable pulse. At that point, it’s functionally the same as cardiac arrest. On a monitor, pulseless VT typically shows a wide, regular waveform repeating at a rapid clip, often in the range of 150 to 250 beats per minute. Unlike VF’s chaotic scribble, VT tends to look organized, though equally deadly when no blood is getting out.

Pulseless VT is treated identically to VF in the field: immediate defibrillation. The key clinical nuance is that VT with a pulse is a medical emergency but not yet cardiac arrest. In that scenario, other interventions like medications or synchronized cardioversion might be tried first. But once the pulse disappears, the protocol switches to full cardiac arrest management with shocks and CPR.

Asystole

Asystole is the flatline. It represents the complete absence of electrical and mechanical heart activity. There’s nothing for a defibrillator to “reset” because there’s no electrical signal present at all, which is why shocking asystole is pointless and not recommended. This is the rhythm with the worst prognosis. Among sudden cardiac arrest victims who present with asystole as their initial rhythm, roughly 10% survive long enough to be admitted to the hospital, and the survival-to-discharge rate hovers near zero to 2%.³

Asystole often represents the end stage of another lethal rhythm. A person who starts in VF, for example, will eventually deteriorate into asystole if no intervention happens. By the time asystole is the presenting rhythm, the heart has typically been without effective circulation for a prolonged period, and the underlying cause is often severe. Treatment focuses on high-quality CPR, epinephrine, and identifying reversible causes like severe blood loss, hypothermia, or drug overdose. Even with aggressive treatment, outcomes remain grim.

Pulseless Electrical Activity

PEA is perhaps the most frustrating rhythm for clinicians because the heart monitor shows organized electrical activity that looks like it should produce a heartbeat, but no pulse can be found. The electrical system is firing, but the heart muscle either can’t respond or can’t generate enough force to circulate blood. Think of it as the wiring working while the pump fails.

The causes of PEA are wide-ranging and include massive blood loss, tension pneumothorax (a collapsed lung under pressure), cardiac tamponade (fluid compressing the heart), severe electrolyte imbalances, and acute coronary artery blockage. Research has shown that in patients with already-weakened hearts, PEA can develop almost immediately after a coronary artery becomes blocked, much faster than VF would, sometimes within two minutes of the onset of ischemia compared to roughly twenty minutes for VF to develop in the same setting.⁴ Like asystole, PEA is non-shockable. Treatment hinges on CPR, medications, and aggressively hunting for the underlying cause.

Torsades de Pointes

Torsades de pointes, French for “twisting of the points,” is a specific and visually distinctive form of VT that occurs in the setting of a prolonged QT interval on the ECG. On a monitor, the waveform appears to rotate around the baseline, with the peaks and valleys of the complexes rising and falling in a characteristic undulating pattern. It can degenerate into VF and full cardiac arrest, which is what makes it lethal.

The QT prolongation that sets the stage for torsades can be inherited or acquired. The acquired form, which is far more common, is triggered by medications and metabolic conditions that alter the flow of potassium, sodium, or calcium ions across heart cells. Specifically, these triggers reduce the potassium currents that help the heart return to its resting electrical state after each beat, or they enhance inward sodium and calcium currents, creating abnormal electrical impulses that kick off the arrhythmia.⁵ Dozens of commonly prescribed drugs have been linked to QT prolongation, including certain antibiotics, antipsychotics, and anti-nausea medications.

Treatment of torsades differs from standard VF or VT management. Intravenous magnesium is the first-line drug, and if the patient has a slow underlying heart rate, temporary pacing can help. If torsades degenerates into VF, then standard defibrillation applies. The distinction matters because giving standard anti-arrhythmic drugs used for other forms of VT can actually worsen torsades.

Why Every Minute Counts for the Shockable Rhythms

For VF and pulseless VT, the clock starts ticking the moment the heart stops. A large study of out-of-hospital cardiac arrests found that the proportion of patients whose VF was successfully terminated by the first shock dropped from about 93% when the shock came within six minutes down to about 75% when it was delayed beyond sixteen minutes. Every additional minute of VF from the time of the emergency call was associated with a 6% higher chance that the shock would fail to terminate the rhythm and a 6% lower chance of surviving to hospital discharge.⁶

Separately, when researchers looked at neurological outcomes, each one-minute delay in getting the first defibrillation was linked to roughly a 7% decrease in the odds of a good neurological recovery.⁷ These numbers underscore why bystander use of AEDs before paramedics arrive can make the difference between someone walking out of the hospital and someone who doesn’t survive.

What CPR and Medications Actually Do During a Cardiac Arrest

CPR doesn’t restart the heart. Its job is to manually pump enough blood to keep the brain and heart muscle alive until a definitive treatment, like defibrillation or correction of an underlying cause, can be delivered. The critical measurement is coronary perfusion pressure, essentially the blood pressure gradient that forces blood into the heart’s own arteries during the decompression phase of each chest compression.⁸ Interrupting compressions, even briefly, causes that pressure to drop, and it takes several compressions to build it back up. This is why current guidelines emphasize minimizing pauses during CPR.

On the medication side, epinephrine is the cornerstone drug given during cardiac arrest regardless of rhythm type. It constricts blood vessels throughout the body, which helps redirect whatever blood CPR generates toward the heart and brain. However, the evidence for epinephrine is more complicated than you might expect. While it does improve the chance of getting a pulse back, studies comparing it to placebo have shown at best no difference in long-term neurological outcomes, and in some cases potentially worse brain function among survivors.⁹ It’s one of the more uncomfortable realities of resuscitation medicine: a drug that helps restart the heart may not help the brain that goes with it.

For VF and pulseless VT that persist after multiple shocks, amiodarone is the anti-arrhythmic drug most commonly given. In a landmark trial, patients who received amiodarone during refractory VF were significantly more likely to survive to hospital admission compared to placebo, with about 44% surviving to admission versus 34%.¹⁰

Common Triggers Behind Lethal Rhythms

Coronary artery disease remains the most common cause of sudden cardiac arrest. When a coronary artery becomes blocked, the affected heart muscle loses its blood supply, and the resulting ischemia disrupts normal electrical signaling. In the first minutes of ischemia, abnormal calcium handling inside heart cells can spark the electrical chaos that becomes VF.¹¹

Electrolyte imbalances are another major trigger, particularly severe hyperkalemia (high potassium levels in the blood). Potassium plays a central role in the electrical cycle of every heartbeat, and when blood levels spike, the heart’s electrical system can slow dangerously, widen its electrical complexes, and ultimately produce VF, PEA, or asystole.¹² Kidney failure, certain medications, and tissue breakdown are common causes of hyperkalemia.

Inherited conditions also play a role, particularly in younger people who experience sudden cardiac arrest without obvious heart disease. Long QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT) are genetic disorders affecting the heart’s ion channels that can trigger VF or torsades de pointes, sometimes during exercise or emotional stress.¹³ In some cases, conduction system disease like complete heart block can progress to VF and sudden death as well.¹⁴

What Happens After the Heart Restarts

Getting a pulse back is only the beginning. The period after return of spontaneous circulation is dangerous in its own right, and many patients who initially survive a cardiac arrest die in the following hours or days from brain injury or recurrent arrest. One of the biggest concerns is secondary brain injury caused by inflammation, swelling, and increased metabolic demand in brain tissue that was starved of oxygen during the arrest. Elevated body temperature amplifies all of these processes, increasing seizure risk and brain edema.¹⁵ Current practice involves carefully managing the patient’s temperature in the hours after resuscitation, though the optimal target temperature remains a matter of active research and debate.

For patients at ongoing risk of lethal rhythms, implantable cardioverter-defibrillators (ICDs) can be placed. These small devices continuously monitor the heart’s rhythm and deliver an internal shock if VF or VT is detected. Evidence supports their effectiveness in reducing sudden cardiac death even in patients receiving modern guideline-based medical therapy.¹⁶

Smartwatches and Early Arrhythmia Detection

Consumer wearable technology has begun to blur the line between personal gadget and medical device. Recent case reports have documented smartwatches accurately detecting sustained ventricular tachycardia in real time, using a combination of light-based pulse sensors and single-lead ECG recordings. In one case, a patient’s smartwatch captured a wide complex tachycardia running at 165 beats per minute, which was later confirmed as VT.¹⁷

The potential here extends beyond standalone detection. Even in patients who already have an ICD, a smartwatch may pick up slower forms of VT that fall below the ICD’s programmed detection threshold. Recording an ECG during symptoms gives doctors data they can use to reprogram the device or change medications. Researchers see this as a rapidly evolving area where artificial intelligence algorithms for arrhythmia classification could significantly expand the role of wearables in the near future.¹⁸ To be clear, a smartwatch can’t deliver a shock or replace emergency care. But catching a dangerous rhythm before it becomes pulseless could save critical time.

Why Bystanders Hesitate to Use AEDs

AEDs are designed to be used by people with no medical training. They give voice instructions, analyze the rhythm automatically, and will only deliver a shock when VF or pulseless VT is detected. You genuinely cannot shock someone who doesn’t need it with a modern AED. Yet despite their effectiveness and simplicity, bystander AED use remains strikingly low during out-of-hospital cardiac arrests.

Research into the barriers reveals a mix of practical and psychological obstacles. Fear of legal liability is a major concern, as is anxiety about harming the victim or using the device incorrectly. Unequal access to CPR training across socioeconomic, age, and racial groups compounds the problem, as does limited awareness of where AEDs are located in public spaces.¹⁹ Interestingly, studies have found that higher education and younger age actually predicted more worry about taking responsibility for AED use, not less, possibly because those groups overthink the potential consequences.²⁰ Good Samaritan laws in most jurisdictions specifically protect bystanders who use an AED in good faith, but awareness of those protections remains low. Given that every minute without defibrillation in VF drops survival chances substantially, the gap between how well AEDs work and how rarely they get used is one of the biggest missed opportunities in emergency cardiac care.